SCHEMBL6568660

SCHEMBL6568660

N#CCC(=O)Nc1cc(Cl)c(O)c(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 10/20 0.50
CYP1A2 P05177 1/20 0.48
CYP2C19 P33261 1/20 0.48
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45
POLB P06746 1/20 0.45
HTT P42858 2/20 0.44
HSD17B10 Q99714 2/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
HPGD P15428 1/20 0.43
AGPAT2 O15120 2/20 0.43
RECQL P46063 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11137005 0.88 ABL1 (0.51) ABL1CYP1A2CYP2C19CA12CA1
SCHEMBL11435532 0.85 CA12 (0.50) ABL1CYP1A2CYP2C19CA12CA1
SCHEMBL9819103 0.82 ACP1 (0.53) ABL1CYP1A2CYP2C19CA12CA1
SCHEMBL9819126 0.81 CYP3A4 (0.63) ABL1CYP1A2CYP2C19CA12CA1
SCHEMBL8072208 0.80 CA12 (0.51) ABL1CYP1A2CYP2C19CA12CA1
SCHEMBL4620182 0.78 TSHR (0.66) CYP1A2CYP2C19KMT2AMEN1HTT
SCHEMBL11140544 0.78 ALDH1A1 (0.69) CYP1A2CYP2C19CA2KMT2AMEN1
SCHEMBL16150319 0.77 CYP3A4 (0.66) KMT2AMEN1POLBMAPTALDH1A1
SCHEMBL11122026 0.75 CA12 (0.73) ABL1CYP1A2CYP2C19CA12CA1
SCHEMBL1618221 0.75 ALDH1A1 (0.64) ABL1CYP1A2CYP2C19CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed